Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 2 |
2015 | 1 |
2016 | 3 |
2017 | 2 |
2018 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer.
Cancer Causes Control. 2018 Aug;29(8):785-791. doi: 10.1007/s10552-018-1050-z. Epub 2018 Jun 29.
Cancer Causes Control. 2018.
PMID: 29959604
Free PMC article.
Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.
Fu AZ, Tsai HT, Haque R, Yood MU, Cassidy-Bushrow AE, Van Den Eeden SK, Keating NL, Smith MR, Zhou Y, Aaronson DS, Potosky AL.
Fu AZ, et al.
J Urol. 2017 Jun;197(6):1448-1454. doi: 10.1016/j.juro.2016.12.086. Epub 2016 Dec 19.
J Urol. 2017.
PMID: 28007467
Free PMC article.
Item in Clipboard
Risks of Serious Toxicities from Intermittent versus Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study.
Tsai HT, Pfeiffer RM, Philips GK, Barac A, Fu AZ, Penson DF, Zhou Y, Potosky AL.
Tsai HT, et al.
J Urol. 2017 May;197(5):1251-1257. doi: 10.1016/j.juro.2016.12.022. Epub 2016 Dec 16.
J Urol. 2017.
PMID: 27993663
Free PMC article.
Item in Clipboard
Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.
Fu AZ, Tsai HT, Haque R, Ulcickas Yood M, Van Den Eeden SK, Cassidy-Bushrow AE, Zhou Y, Keating NL, Smith MR, Aaronson DS, Potosky AL.
Fu AZ, et al.
World J Urol. 2016 Dec;34(12):1611-1619. doi: 10.1007/s00345-016-1823-5. Epub 2016 Apr 15.
World J Urol. 2016.
PMID: 27084777
Free PMC article.
Item in Clipboard
Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer.
Tsai HT, Keating NL, Van Den Eeden SK, Haque R, Cassidy-Bushrow AE, Ulcickas Yood M, Smith MR, Potosky AL.
Tsai HT, et al.
J Urol. 2015 Jun;193(6):1956-62. doi: 10.1016/j.juro.2014.12.027. Epub 2014 Dec 15.
J Urol. 2015.
PMID: 25524243
Free PMC article.
Item in Clipboard
Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer.
Potosky AL, Haque R, Cassidy-Bushrow AE, Ulcickas Yood M, Jiang M, Tsai HT, Luta G, Keating NL, Smith MR, Van Den Eeden SK.
Potosky AL, et al.
J Clin Oncol. 2014 May 1;32(13):1324-30. doi: 10.1200/JCO.2013.52.5782. Epub 2014 Mar 17.
J Clin Oncol. 2014.
PMID: 24638009
Free PMC article.
Item in Clipboard
Cite
Cite